APO Research
Talk to an analyst

APO RESEARCH · REPORT

Finasteride Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Finasteride Tablets Market Outlook and Growth Opportunities 2026

20 December 2025198 pages

Choose your research edition.

Industry ResearchFinasteride Tablets Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Finasteride Tablets Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Finasteride Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Finasteride Tablets Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Finasteride Tablets Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Finasteride Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Finasteride Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Finasteride Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Finasteride Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Finasteride Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Finasteride Tablets market include Accord Pharmaceuticals, Actavis, Cipla, Dr. Reddy, RelonChem, Guangdong Eashu Pharmacetical, Henan Topfond, Zhejiang CONBA Pharmaceutical and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Finasteride Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Finasteride Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Finasteride Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Finasteride Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Finasteride Tablets Segment by Company

Accord Pharmaceuticals

Actavis

Cipla

Dr. Reddy

RelonChem

Guangdong Eashu Pharmacetical

Henan Topfond

Zhejiang CONBA Pharmaceutical

Merck

Shandong Renhetang Pharmaceutical

Sandoz

Teva Pharmaceuticals

Finasteride Tablets Segment by Type

1mg Tablet

5mg Tablet

Finasteride Tablets Segment by Application

Benign Prostatic Hyperplasia

Male Pattern Baldness

Others

Finasteride Tablets Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Finasteride Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Finasteride Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Finasteride Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Finasteride Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Finasteride Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Finasteride Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Finasteride Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Finasteride Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Finasteride Tablets industry.

Chapter 3: Detailed analysis of Finasteride Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Finasteride Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Finasteride Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Finasteride Tablets Industry Trends Table 2. Finasteride Tablets Industry Drivers Table 3. Finasteride Tablets Industry Opportunities and Challenges Table 4. Finasteride Tablets Industry Restraints Table 5. Global Finasteride Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Finasteride Tablets Revenue Share by Company (2021-2026) Table 7. Global Finasteride Tablets Sales Volume by Company (W Pcs) & (2021-2026) Table 8. Global Finasteride Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Finasteride Tablets Average Price (US$/Pcs) of Company (2021-2026) Table 10. Global Finasteride Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Finasteride Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Finasteride Tablets Company, Product Type & Application Table 13. Global Finasteride Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Finasteride Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 1mg Tablet Table 18. Significant Companies of 5mg Tablet Table 19. Global Finasteride Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (W Pcs) Table 20. Global Finasteride Tablets Sales Volume by Type (2021-2026) & (W Pcs) Table 21. Global Finasteride Tablets Sales Volume by Type (2027-2032) & (W Pcs) Table 22. Global Finasteride Tablets Sales Volume Share by Type (2021-2026) Table 23. Global Finasteride Tablets Sales Volume Share by Type (2027-2032) Table 24. Global Finasteride Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Finasteride Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Finasteride Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Finasteride Tablets Sales Value Share by Type (2021-2026) Table 28. Global Finasteride Tablets Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Benign Prostatic Hyperplasia Table 30. Significant Companies of Male Pattern Baldness Table 31. Significant Companies of Others Table 32. Global Finasteride Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (W Pcs) Table 33. Global Finasteride Tablets Sales Volume by Application (2021-2026) & (W Pcs) Table 34. Global Finasteride Tablets Sales Volume by Application (2027-2032) & (W Pcs) Table 35. Global Finasteride Tablets Sales Volume Share by Application (2021-2026) Table 36. Global Finasteride Tablets Sales Volume Share by Application (2027-2032) Table 37. Global Finasteride Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Finasteride Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Finasteride Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Finasteride Tablets Sales Value Share by Application (2021-2026) Table 41. Global Finasteride Tablets Sales Value Share by Application (2027-2032) Table 42. Global Finasteride Tablets Sales by Region: 2021 VS 2025 VS 2032 (W Pcs) Table 43. Global Finasteride Tablets Sales by Region (2021-2026) & (W Pcs) Table 44. Global Finasteride Tablets Sales Market Share by Region (2021-2026) Table 45. Global Finasteride Tablets Sales by Region (2027-2032) & (W Pcs) Table 46. Global Finasteride Tablets Sales Market Share by Region (2027-2032) Table 47. Global Finasteride Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Finasteride Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Finasteride Tablets Sales Value Share by Region (2021-2026) Table 50. Global Finasteride Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Finasteride Tablets Sales Value Share by Region (2027-2032) Table 52. Global Finasteride Tablets Market Average Price (US$/Pcs) by Region (2021-2026) Table 53. Global Finasteride Tablets Market Average Price (US$/Pcs) by Region (2027-2032) Table 54. Global Finasteride Tablets Sales by Country: 2021 VS 2025 VS 2032 (W Pcs) Table 55. Global Finasteride Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Finasteride Tablets Sales by Country (2021-2026) & (W Pcs) Table 57. Global Finasteride Tablets Sales Market Share by Country (2021-2026) Table 58. Global Finasteride Tablets Sales by Country (2027-2032) & (W Pcs) Table 59. Global Finasteride Tablets Sales Market Share by Country (2027-2032) Table 60. Global Finasteride Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Finasteride Tablets Sales Value Market Share by Country (2021-2026) Table 62. Global Finasteride Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Finasteride Tablets Sales Value Market Share by Country (2027-2032) Table 64. Accord Pharmaceuticals Company Information Table 65. Accord Pharmaceuticals Business Overview Table 66. Accord Pharmaceuticals Finasteride Tablets Sales (W Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 67. Accord Pharmaceuticals Finasteride Tablets Product Portfolio Table 68. Accord Pharmaceuticals Recent Development Table 69. Actavis Company Information Table 70. Actavis Business Overview Table 71. Actavis Finasteride Tablets Sales (W Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 72. Actavis Finasteride Tablets Product Portfolio Table 73. Actavis Recent Development Table 74. Cipla Company Information Table 75. Cipla Business Overview Table 76. Cipla Finasteride Tablets Sales (W Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 77. Cipla Finasteride Tablets Product Portfolio Table 78. Cipla Recent Development Table 79. Dr. Reddy Company Information Table 80. Dr. Reddy Business Overview Table 81. Dr. Reddy Finasteride Tablets Sales (W Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 82. Dr. Reddy Finasteride Tablets Product Portfolio Table 83. Dr. Reddy Recent Development Table 84. RelonChem Company Information Table 85. RelonChem Business Overview Table 86. RelonChem Finasteride Tablets Sales (W Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 87. RelonChem Finasteride Tablets Product Portfolio Table 88. RelonChem Recent Development Table 89. Guangdong Eashu Pharmacetical Company Information Table 90. Guangdong Eashu Pharmacetical Business Overview Table 91. Guangdong Eashu Pharmacetical Finasteride Tablets Sales (W Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 92. Guangdong Eashu Pharmacetical Finasteride Tablets Product Portfolio Table 93. Guangdong Eashu Pharmacetical Recent Development Table 94. Henan Topfond Company Information Table 95. Henan Topfond Business Overview Table 96. Henan Topfond Finasteride Tablets Sales (W Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 97. Henan Topfond Finasteride Tablets Product Portfolio Table 98. Henan Topfond Recent Development Table 99. Zhejiang CONBA Pharmaceutical Company Information Table 100. Zhejiang CONBA Pharmaceutical Business Overview Table 101. Zhejiang CONBA Pharmaceutical Finasteride Tablets Sales (W Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 102. Zhejiang CONBA Pharmaceutical Finasteride Tablets Product Portfolio Table 103. Zhejiang CONBA Pharmaceutical Recent Development Table 104. Merck Company Information Table 105. Merck Business Overview Table 106. Merck Finasteride Tablets Sales (W Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 107. Merck Finasteride Tablets Product Portfolio Table 108. Merck Recent Development Table 109. Shandong Renhetang Pharmaceutical Company Information Table 110. Shandong Renhetang Pharmaceutical Business Overview Table 111. Shandong Renhetang Pharmaceutical Finasteride Tablets Sales (W Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 112. Shandong Renhetang Pharmaceutical Finasteride Tablets Product Portfolio Table 113. Shandong Renhetang Pharmaceutical Recent Development Table 114. Sandoz Company Information Table 115. Sandoz Business Overview Table 116. Sandoz Finasteride Tablets Sales (W Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 117. Sandoz Finasteride Tablets Product Portfolio Table 118. Sandoz Recent Development Table 119. Teva Pharmaceuticals Company Information Table 120. Teva Pharmaceuticals Business Overview Table 121. Teva Pharmaceuticals Finasteride Tablets Sales (W Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 122. Teva Pharmaceuticals Finasteride Tablets Product Portfolio Table 123. Teva Pharmaceuticals Recent Development Table 124. Key Raw Materials Table 125. Raw Materials Key Suppliers Table 126. Finasteride Tablets Distributors List Table 127. Finasteride Tablets Customers List Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Finasteride Tablets Product Image Figure 2. Global Finasteride Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Finasteride Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Finasteride Tablets Sales (2021-2032) & (W Pcs) Figure 5. Global Finasteride Tablets Sales Average Price (US$/Pcs) & (2021-2032) Figure 6. Global Finasteride Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 1mg Tablet Image Figure 10. 5mg Tablet Image Figure 11. Global Finasteride Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (W Pcs) Figure 12. Global Finasteride Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Finasteride Tablets Sales Volume Share by Type (2021-2032) Figure 14. Global Finasteride Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Finasteride Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Finasteride Tablets Sales Value Share by Type (2021-2032) Figure 17. Benign Prostatic Hyperplasia Image Figure 18. Male Pattern Baldness Image Figure 19. Others Image Figure 20. Global Finasteride Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (W Pcs) Figure 21. Global Finasteride Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Finasteride Tablets Sales Volume Share by Application (2021-2032) Figure 23. Global Finasteride Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Finasteride Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Finasteride Tablets Sales Value Share by Application (2021-2032) Figure 26. Global Finasteride Tablets Sales by Region: 2021 VS 2025 VS 2032 (W Pcs) Figure 27. Global Finasteride Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Finasteride Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Finasteride Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Finasteride Tablets Sales Value (2021-2032) & (US$ Million) Figure 31. North America Finasteride Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Finasteride Tablets Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Finasteride Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Finasteride Tablets Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Finasteride Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Finasteride Tablets Sales Value (2021-2032) & (US$ Million) Figure 37. South America Finasteride Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Finasteride Tablets Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Finasteride Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Finasteride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Finasteride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Finasteride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Finasteride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Finasteride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Finasteride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Finasteride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Finasteride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Finasteride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Finasteride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Finasteride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Finasteride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Finasteride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Finasteride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Finasteride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Finasteride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Finasteride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Finasteride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Finasteride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Finasteride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Finasteride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Finasteride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Finasteride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Finasteride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Finasteride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Finasteride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Finasteride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Finasteride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Finasteride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Finasteride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Finasteride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Finasteride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Finasteride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Finasteride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Finasteride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Finasteride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Finasteride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Finasteride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Finasteride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Finasteride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Finasteride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Finasteride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Finasteride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Finasteride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Finasteride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Finasteride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Finasteride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Finasteride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Finasteride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Finasteride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Finasteride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Finasteride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Finasteride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Finasteride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Finasteride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Finasteride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Finasteride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Finasteride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Finasteride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Finasteride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Finasteride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Finasteride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Finasteride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Finasteride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Finasteride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Finasteride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Finasteride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Finasteride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Finasteride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Finasteride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Finasteride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Finasteride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Finasteride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Finasteride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Finasteride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Finasteride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Finasteride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Finasteride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Finasteride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Finasteride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Finasteride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Finasteride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Finasteride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Finasteride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Finasteride Tablets Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Finasteride Tablets Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 1mg Tablet
  • 5mg Tablet
Applications
  • Benign Prostatic Hyperplasia
  • Male Pattern Baldness
  • Others
Companies covered
  • Accord Pharmaceuticals
  • Actavis
  • Cipla
  • Dr. Reddy
  • RelonChem
  • Guangdong Eashu Pharmacetical
  • Henan Topfond
  • Zhejiang CONBA Pharmaceutical
  • Merck
  • Shandong Renhetang Pharmaceutical
  • Sandoz
  • Teva Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Finasteride Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Finasteride Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Finasteride Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Finasteride Tablets Market Dynamics
  1. 2.1 Finasteride Tablets Industry Trends
  2. 2.2 Finasteride Tablets Industry Drivers
  3. 2.3 Finasteride Tablets Industry Opportunities and Challenges
  4. 2.4 Finasteride Tablets Industry Restraints
3 Finasteride Tablets Market by Company
  1. 3.1 Global Finasteride Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Finasteride Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Finasteride Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Finasteride Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Finasteride Tablets Company Ranking (2024-2026)
  6. 3.6 Global Finasteride Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Finasteride Tablets Company Product Type and Application
  8. 3.8 Global Finasteride Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Finasteride Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Finasteride Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Finasteride Tablets Market by Type
  1. 4.1 Finasteride Tablets Type Introduction
  2. 4.1.1 1mg Tablet
  3. 4.1.2 5mg Tablet
  4. 4.2 Global Finasteride Tablets Sales Volume by Type
  5. 4.2.1 Global Finasteride Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Finasteride Tablets Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Finasteride Tablets Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Finasteride Tablets Sales Value by Type
  9. 4.3.1 Global Finasteride Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Finasteride Tablets Sales Value by Type (2021-2032)
  11. 4.3.3 Global Finasteride Tablets Sales Value Share by Type (2021-2032)
5 Finasteride Tablets Market by Application
  1. 5.1 Finasteride Tablets Application Introduction
  2. 5.1.1 Benign Prostatic Hyperplasia
  3. 5.1.2 Male Pattern Baldness
  4. 5.1.3 Others
  5. 5.2 Global Finasteride Tablets Sales Volume by Application
  6. 5.2.1 Global Finasteride Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Finasteride Tablets Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Finasteride Tablets Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Finasteride Tablets Sales Value by Application
  10. 5.3.1 Global Finasteride Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Finasteride Tablets Sales Value by Application (2021-2032)
  12. 5.3.3 Global Finasteride Tablets Sales Value Share by Application (2021-2032)
6 Finasteride Tablets Regional Sales and Value Analysis
  1. 6.1 Global Finasteride Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Finasteride Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Finasteride Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Finasteride Tablets Sales by Region (2027-2032)
  5. 6.3 Global Finasteride Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Finasteride Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Finasteride Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Finasteride Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Finasteride Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Finasteride Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Finasteride Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Finasteride Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Finasteride Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Finasteride Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Finasteride Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Finasteride Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Finasteride Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Finasteride Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Finasteride Tablets Sales Value Share by Country, 2025 VS 2032
7 Finasteride Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Finasteride Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Finasteride Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Finasteride Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Finasteride Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Finasteride Tablets Sales by Country (2027-2032)
  6. 7.4 Global Finasteride Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Finasteride Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Finasteride Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Finasteride Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Finasteride Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Finasteride Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Finasteride Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Finasteride Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Finasteride Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Finasteride Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Finasteride Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Finasteride Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Finasteride Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Finasteride Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Finasteride Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Finasteride Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Finasteride Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Finasteride Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Finasteride Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Finasteride Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Finasteride Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Finasteride Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Finasteride Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Finasteride Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Finasteride Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Finasteride Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Finasteride Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Finasteride Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Finasteride Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Finasteride Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Finasteride Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Finasteride Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Finasteride Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Finasteride Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Finasteride Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Finasteride Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Finasteride Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Finasteride Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Finasteride Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Finasteride Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Finasteride Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Finasteride Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Finasteride Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Finasteride Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Finasteride Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Finasteride Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Finasteride Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Finasteride Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Finasteride Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Finasteride Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Finasteride Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Finasteride Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Finasteride Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Finasteride Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Finasteride Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Finasteride Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Finasteride Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Finasteride Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Finasteride Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Finasteride Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Finasteride Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Finasteride Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Finasteride Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Finasteride Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Finasteride Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Finasteride Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Finasteride Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Finasteride Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Finasteride Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Finasteride Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Finasteride Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Finasteride Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Finasteride Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Finasteride Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Finasteride Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Finasteride Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Finasteride Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Finasteride Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Finasteride Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Finasteride Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Finasteride Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Finasteride Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Finasteride Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Finasteride Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Finasteride Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Finasteride Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Finasteride Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Accord Pharmaceuticals
  2. 8.1.1 Accord Pharmaceuticals Company Information
  3. 8.1.2 Accord Pharmaceuticals Business Overview
  4. 8.1.3 Accord Pharmaceuticals Finasteride Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Accord Pharmaceuticals Finasteride Tablets Product Portfolio
  6. 8.1.5 Accord Pharmaceuticals Recent Developments
  7. 8.2 Actavis
  8. 8.2.1 Actavis Company Information
  9. 8.2.2 Actavis Business Overview
  10. 8.2.3 Actavis Finasteride Tablets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Actavis Finasteride Tablets Product Portfolio
  12. 8.2.5 Actavis Recent Developments
  13. 8.3 Cipla
  14. 8.3.1 Cipla Company Information
  15. 8.3.2 Cipla Business Overview
  16. 8.3.3 Cipla Finasteride Tablets Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Cipla Finasteride Tablets Product Portfolio
  18. 8.3.5 Cipla Recent Developments
  19. 8.4 Dr. Reddy
  20. 8.4.1 Dr. Reddy Company Information
  21. 8.4.2 Dr. Reddy Business Overview
  22. 8.4.3 Dr. Reddy Finasteride Tablets Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Dr. Reddy Finasteride Tablets Product Portfolio
  24. 8.4.5 Dr. Reddy Recent Developments
  25. 8.5 RelonChem
  26. 8.5.1 RelonChem Company Information
  27. 8.5.2 RelonChem Business Overview
  28. 8.5.3 RelonChem Finasteride Tablets Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 RelonChem Finasteride Tablets Product Portfolio
  30. 8.5.5 RelonChem Recent Developments
  31. 8.6 Guangdong Eashu Pharmacetical
  32. 8.6.1 Guangdong Eashu Pharmacetical Company Information
  33. 8.6.2 Guangdong Eashu Pharmacetical Business Overview
  34. 8.6.3 Guangdong Eashu Pharmacetical Finasteride Tablets Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Guangdong Eashu Pharmacetical Finasteride Tablets Product Portfolio
  36. 8.6.5 Guangdong Eashu Pharmacetical Recent Developments
  37. 8.7 Henan Topfond
  38. 8.7.1 Henan Topfond Company Information
  39. 8.7.2 Henan Topfond Business Overview
  40. 8.7.3 Henan Topfond Finasteride Tablets Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Henan Topfond Finasteride Tablets Product Portfolio
  42. 8.7.5 Henan Topfond Recent Developments
  43. 8.8 Zhejiang CONBA Pharmaceutical
  44. 8.8.1 Zhejiang CONBA Pharmaceutical Company Information
  45. 8.8.2 Zhejiang CONBA Pharmaceutical Business Overview
  46. 8.8.3 Zhejiang CONBA Pharmaceutical Finasteride Tablets Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Zhejiang CONBA Pharmaceutical Finasteride Tablets Product Portfolio
  48. 8.8.5 Zhejiang CONBA Pharmaceutical Recent Developments
  49. 8.9 Merck
  50. 8.9.1 Merck Company Information
  51. 8.9.2 Merck Business Overview
  52. 8.9.3 Merck Finasteride Tablets Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Merck Finasteride Tablets Product Portfolio
  54. 8.9.5 Merck Recent Developments
  55. 8.10 Shandong Renhetang Pharmaceutical
  56. 8.10.1 Shandong Renhetang Pharmaceutical Company Information
  57. 8.10.2 Shandong Renhetang Pharmaceutical Business Overview
  58. 8.10.3 Shandong Renhetang Pharmaceutical Finasteride Tablets Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Shandong Renhetang Pharmaceutical Finasteride Tablets Product Portfolio
  60. 8.10.5 Shandong Renhetang Pharmaceutical Recent Developments
  61. 8.11 Sandoz
  62. 8.11.1 Sandoz Company Information
  63. 8.11.2 Sandoz Business Overview
  64. 8.11.3 Sandoz Finasteride Tablets Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Sandoz Finasteride Tablets Product Portfolio
  66. 8.11.5 Sandoz Recent Developments
  67. 8.12 Teva Pharmaceuticals
  68. 8.12.1 Teva Pharmaceuticals Company Information
  69. 8.12.2 Teva Pharmaceuticals Business Overview
  70. 8.12.3 Teva Pharmaceuticals Finasteride Tablets Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Teva Pharmaceuticals Finasteride Tablets Product Portfolio
  72. 8.12.5 Teva Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Finasteride Tablets Value Chain Analysis
  2. 9.1.1 Finasteride Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Finasteride Tablets Sales Mode & Process
  6. 9.2 Finasteride Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Finasteride Tablets Distributors
  9. 9.2.3 Finasteride Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst